Company

Pulmovant

Biotechnology Research 303 Wyman St 34 employees

Employees: 34
Contacts: 3
Emails: 3
Phones: 1

www.pulmovant.com LinkedIn

Pulmovant Overview

Headquarters: 303 Wyman St
Website: www.pulmovant.com
Industry: Biotechnology Research
Employees: 34
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Pulmovant

Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Mosliciguat is a novel, potential first-in-class, sGC activator with a differentiated mechanism that may have broad applicability across the PH spectrum.

Pulmovant Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Pulmovant Org Chart

Sample employees and titles

Name	Title	Location	Contact
John Blake		San Diego County, California, United States	View
Sammy Messekher		Greater Paris Metropolitan Region, France	Email
Brett Vengroff	GCP, Glp, Cgmp Compliance Training	St Petersburg, Florida, United States	Email Phone
Tracy Forsberg Salsa Rn Bsn Mba	Senior Director, Field Based Medicine	Visalia, California, United States	Email